Skip to main content
CYRX
NASDAQ Life Sciences

Q3 Revenue Jumps 14% to $50.2M, Guidance Raised to $197-199M

Tom Rudovsky · Reported by PR Newswire
More coverage: Transportation & Logistics Stocks · Industrial
Sentiment info
Positive
Importance info
8
Price
$16.05
Mkt Cap
$812.918M
52W Low
$7.61
52W High
$18.88
52W Position info
111% above low
Off High info
15% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

CYRX has more than doubled off its 52-week low of $7.61 on elevated volume (2.2× avg).

Summary

Cryoport beat its own trajectory with Q3 revenue of $50.2 million, up 14% year-over-year from $44.2 million, accelerating from the 7.7% growth reported in Q2 and topping the IBES estimate of USD 48.8 million. Commercial cell and gene therapy revenue rose 20% and BioStorage/BioServices grew 25%, while the company posted positive adjusted EBITDA of $1.1 million versus negative $0.6 million a year ago — its first meaningful step toward profitability. Management raised full-year 2026 revenue guidance to $197-199 million, and the company now supports a record 788 clinical trials and 23 commercial therapies. The offset: net loss widened to $10.9 million from $6.9 million, driven largely by a $4.2 million unrealized loss on investments, and gross margin slipped to 47.5% from 48.2% on weaker product margins. With $393.1 million in cash and short-term investments, the balance sheet is not a near-term concern.

At the time of this announcement, CYRX was trading at $16.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $812.9M. The 52-week trading range was $7.61 to $18.88. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

CYRX - Latest Insights

CYRX
Nov 05, 2026, 5:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $17.81
Real-time Price: $19.55 info
Change: +$1.74 (+10%) info
Market Cap: $991.193M info
CYRX
Jun 12, 2026, 6:38 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $14.21
Real-time Price: $19.55 info
Change: +$5.34 (+38%) info
Market Cap: $991.193M info
CYRX
Jun 09, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $15.19
Real-time Price: $19.55 info
Change: +$4.36 (+29%) info
Market Cap: $991.193M info
CYRX
Jun 08, 2026, 9:11 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $15.48
Real-time Price: $19.55 info
Change: +$4.07 (+26%) info
Market Cap: $991.193M info
CYRX
Jun 03, 2026, 4:35 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $16.50
Real-time Price: $19.55 info
Change: +$3.05 (+18%) info
Market Cap: $991.193M info